| 2025 | 2024 | 2023 | ||||
|---|---|---|---|---|---|---|
| Gross margin | -3,7 k € | +46.4% | -6,9 k € | — | ||
| EBITDA | -3,7 k € | +46.4% | -6,9 k € | — | ||
| Operating profit | -3,7 k € | +46.4% | -6,9 k € | — | ||
| Profit/loss | -4,0 k € | +43.1% | -7,0 k € | — | ||
| Equity | -6,0 k € | -204.3% | -2,0 k € | -138.6% | 5,1 k € | |
| Total assets | 5,3 k € | -20.2% | 6,7 k € | +31.4% | 5,1 k € | |
| Cash | 5,3 k € | +6.7% | 5,0 k € | -2.2% | 5,1 k € | |
| Debts | 11,3 k € | +30.8% | 8,6 k € | — | ||
Private limited company · Leuven · incorporated on 07/12/2023
Private limited company loss-making in the latest fiscal year. Cash position rising (+6.7%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
Key indicators
Raya Therapeutic is a Private limited company incorporated in 2023. Its main activity is: Manufacture of basic pharmaceutical products. Its registered office is in Leuven.